You are here

Astellas

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

Seeking Alpha

Sat, 05/4/13 - 10:32 am

Vertex Pharmaceuticals

Peregrine Pharmaceuticals

Navidea Biopharmaceuticals

Cardinal Health

ONYX Pharmaceuticals

Hyperion Therapeutics

Sangamo BioSciences

Astellas, GSK vie to make 'high altitude' anemia pill

Reuters

Fri, 04/19/13 - 08:52 am

GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment

Outsourcing Pharma

Thu, 04/18/13 - 08:21 am

restless legs syndrome

Optimer Said to Draw Takeover Interest From Glaxo, Astellas

Bloomberg

Tue, 04/2/13 - 10:04 am

Optimer Pharmaceuticals

Cubist Pharmaceuticals

Medivation, Astellas Pharma provide update on Phase 3 PREVAIL

Yahoo/Fly on the Wall

Mon, 04/1/13 - 10:49 am

metastatic castration-resistant prostate cancer

prostate cancer

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Motley Fool

Wed, 03/20/13 - 11:56 am

Cubist Pharma buys out antibiotic partner Astellas for $25M-plus

Fierce Biotech

Mon, 03/11/13 - 12:34 pm

Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players

Motley Fool

Wed, 03/6/13 - 09:49 am

prostate cancer

Johnson & Johnson's Pioneering Zytiga And Its Competitors

Seeking Alpha

Sun, 02/24/13 - 02:26 pm

Zytiga. ARN-509

prostate cancer

Which Biotech Company Will Be Bought Out Next?

Motley Fool

Sun, 01/27/13 - 11:18 am

FDA fast tracks two new lung cancer drugs

PM Live

Fri, 01/18/13 - 10:17 am

Boehringer Ingelheim

non-small cell lung cancer

Zytiga, Xtandi will help pump prostate cancer market to $9.1B

Fierce Pharma

Tue, 11/13/12 - 05:45 pm

prostate cancer

Medivation Prostate Cancer Drug Launches Hot

TheStreet.com

Thu, 11/1/12 - 11:50 am

prostate cancer

Astellas launches bladder drug, aiming for a $1.9B franchise

Fierce Pharma

Mon, 10/22/12 - 12:11 pm

overactive bladder

J&J and Astellas Collaborate

Yahoo/Zacks

Thu, 10/4/12 - 10:42 am

rheumatoid arthritis

Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study

Yahoo/MarketWire

Sun, 09/30/12 - 10:34 am

prostate cancer

Abbott inks pact with Astellas Pharma in Phase 3 clinical trial for ASP0113

Healthcare Global

Sat, 09/8/12 - 11:33 am

cytomegalovirus

Abbott to Collaborate with Astellas in CMV Vaccine Trial

Yahoo

Thu, 09/6/12 - 10:19 am

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

Motley Fool

Fri, 08/31/12 - 12:27 pm

Decision Date for Medivation Drug

Yahoo/Zacks

Tue, 08/7/12 - 05:53 pm

prostate cancer

Pages